Message Boards
Today's Active Topics Today's Active Cases Browse Forum Categories My Recent Activity My Messages Private Groups My Marked Threads My Subscriptions
Today's Active Images Today's Active Polls Most Active Topics Global Townie Map Advanced Message Board Search Message Board Terms of Use

Vivos Therapeutics and Candid Collaborate to Deliver Sleep Apnea and Orthodontic Treatment Solution

Start Discussion
Posted: November 30, 2021
Edited by Dentaltown staff

HIGHLANDS RANCH, Colo.—Vivos Therapeutics, a medical technology company focused on developing and commercializing diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (OSA) and snoring, and Candid, a digital platform for oral health care, announced a new collaboration that will seek to provide patients with a comprehensive, whole-mouth solution to diagnose and treat OSA in adult patients and provide orthodontic treatment from the same provider network.

At the core of this collaboration, Vivos and Candid will market each company’s products and areas of expertise to deliver a comprehensive sleep and oral health solution to patients in the United States and Canada.  The focus of the collaboration will be Candid’s CandidPro clear aligner for straightening teeth and the Vivos System for treating OSA.  The two companies will also share educational resources, training and key opinion leaders to bridge the gap between airway health and orthodontic therapy. 

“By teaming with Candid, we are aiming to provide patients with access not only to our highly effective Vivos system, but also simultaneous access to CandidPro’s novel orthodontic treatment. We believe the Vivos-Candid collaboration will provide for the first solution that seamlessly integrates sleep and orthodontic therapy to create better patient outcomes for treating OSA and enhance overall health and wellness across the board.” said Kirk Huntsman, Vivos chairman and CEO. “We are hopeful that this joint effort will increase market penetration and accelerate revenue growth for both companies as we each attract and expand our respective North American dental and health care networks.”

Additionally, under the terms of the agreement, Vivos and Candid will explore new research and development opportunities for device development and other alliances related to orthodontics, OSA and snoring. Candid will also conduct specialized training sessions at the Vivos Institute, the company’s new international training center in Denver, Colorado, as well as semi-annual seminars for both dentists and medical doctors to provide additional learning opportunities. 

“Candid was built on a foundation of clinical excellence and has always put patient health first. Since launching Candid in 2017, my co-founders and I have strived to shine a light on the correlation between teeth alignment, oral health, and chronic illnesses, like obstructive sleep apnea. Vivos Therapeutics and Candid are where airway and sleep, oral health, and orthodontic therapy come together for the first time,” added Nick Greenfield, Candid co-founder and CEO. “By combining Vivos’ therapeutic protocol for OSA and its VIP doctor network with Candid's treatment methodology and CandidPro network, together we look forward to offering a full-service solution for patients suffering from OSA.”
Views: 61
Start Discussion
Dentaltown Magazine
October 2025
Dentaltown Magazine October 2025 Read Current Issue Read Archived Issues
Sponsors
Townie Perks
Townie® Poll
Do you place implants in your practice?
  
Site Menu
Message Boards Magazine Continuing Education Podcasts Blogs Classifieds Dental News Events Townie® Poll Ebooks Townie Choice Awards
Company Info
Contact Us Advertise With Us Howard Farran DDS, MBA Policies and Agreements
Site Help
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@farranmedia.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450